Suggested searches
Quick access
Prostate cancer screening usually starts with a prostate-specific antigen (PSA) blood test. A raised PSA level does not mean you have cancer. It means your doctor may suggest more tests, such as an MRI, before deciding whether a biopsy is needed.
Screening has benefits and limits, so it is worth understanding both before you decide. This guide explains when to consider testing, what a PSA result means, and what happens after an abnormal result.
Prostate cancer screening looks for signs of cancer in men who do not have symptoms. The two main screening methods are the PSA blood test and the digital rectal examination (DRE).
A PSA test measures the level of prostate-specific antigen in the blood. During a DRE, a doctor gently examines the prostate through the rectum to check for unusual firmness, enlargement, or lumps.
Neither test can confirm prostate cancer on its own. Instead, doctors consider the results alongside medical history, urinary symptoms, family history, and other findings to decide whether more tests are needed.
Many international guidelines suggest that men at average risk discuss PSA screening with a doctor from about age 50 (guideline review). Men at higher risk may need to discuss it earlier, often from age 40 to 45. Higher risk includes:
Screening is a personal decision. Your doctor can help you weigh the benefits and limits based on your age, family history, general health, and preferences.
If you are unsure whether screening is right for you, a medical consultation can help you decide on the next steps.
PSA screening can find prostate cancer earlier, sometimes before symptoms appear, when more treatment options may be available. It also has limits that are important to understand:
Research on whether PSA screening reduces deaths from prostate cancer has produced mixed results, although a 2026 Cochrane review found that it likely provides a small reduction. This is why guidelines recommend discussing screening with a doctor rather than testing automatically.
PSA is a protein produced by prostate tissue. A PSA blood test measures how much of this protein is circulating in the bloodstream.
Higher PSA levels can be associated with prostate cancer, but they can also occur for reasons unrelated to cancer, including:
This means an elevated PSA result does not automatically indicate cancer. There is no single PSA number that separates cancer from no cancer, so doctors interpret results in context.
They may recommend repeating the test, reviewing possible contributing factors, or arranging further investigations.
An abnormal PSA result or suspicious DRE does not necessarily mean you have prostate cancer. The next steps help doctors decide whether a biopsy is needed.
Your doctor may review your PSA level, previous results, medications, urinary symptoms, and possible causes of a temporary increase. A repeat blood test may be recommended, and a DRE may be performed if it has not been done already.
A multiparametric MRI provides detailed images of the prostate. A scoring system called PI-RADS helps doctors assess whether any area looks suspicious for clinically significant cancer.
MRI results help decide whether a biopsy is needed and which areas to sample.
A prostate biopsy collects small tissue samples for examination under a microscope. It is the main test used to confirm whether prostate cancer is present.
The biopsy is usually guided by ultrasound, for example transrectal ultrasound (TRUS), sometimes combined with MRI images to target suspicious areas. Doctors recommend a biopsy when PSA results, DRE findings, MRI results, or other clinical information suggest a meaningful risk of cancer.
Not every patient needs every test. The next step depends on the overall assessment and the likelihood of cancer.
If you are considering prostate cancer screening or have received an abnormal PSA result, book a consultation at Bali International Hospital to discuss which tests or follow-up care may be appropriate.
You can also explore our health screening services and medical check-up packages. If further cancer evaluation or treatment is needed, Icon Cancer Centre Bali, located at Bali International Hospital, offers specialist cancer care.
Contact the hospital to ask about PSA testing, urology consultations, and the most suitable next steps for your needs.
A PSA test is a blood test that measures prostate-specific antigen, a protein produced by prostate tissue. Higher levels may indicate prostate cancer, but benign prostate enlargement and inflammation can also increase PSA levels.
Many guidelines suggest men at average risk discuss screening from about age 50. Men with a family history of prostate cancer or a known inherited gene change may need to discuss it earlier, often from age 40 to 45.
A doctor can help determine the right timing for you.
PSA screening can give false alarms that lead to unnecessary biopsies, and it can find slow-growing cancers that would never have caused harm. A normal result also does not completely rule out cancer.
Discuss these trade-offs with your doctor before testing.
A high PSA result means further assessment may be needed, but it does not confirm cancer. Your doctor may review possible causes, repeat the test, perform a DRE, or recommend an MRI or biopsy, depending on your overall risk.
Assessment may include PSA blood testing, a digital rectal examination, and prostate MRI. A prostate biopsy, usually guided by ultrasound, examines tissue samples under a microscope and is the main test used to confirm a prostate cancer diagnosis.